Haesook Teresa Kim

Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation.

Penter L, Zhang Y, Savell A, Huang T, Cieri N, Thrash EM, Kim-Schulze S, Jhaveri A, Fu J, Ranasinghe S, Li S, Zhang W, Hathaway ES, Nazzaro M, Kim HT, Chen H, Thurin M, Rodig SJ, Severgnini M, Cibulskis C, Gabriel S, Livak KJ, Cutler C, Antin JH, Nikiforow S, Koreth J, Ho VT, Armand P, Ritz J, Streicher H, Neuberg D, Hodi FS, Gnjatic S, Soiffer RJ, Liu XS, Davids MS, Bachireddy P, Wu CJ.

Blood. 2021 Jun 10. 137(23):3212-3217. PMID: 33720354

Novel Composite Endpoints after Allogeneic Hematopoietic Cell Transplantation.

Kim HT, Logan B, Weisdorf DJ.

Transplant Cell Ther. 2021 Aug. 27(8):650-657. PMID: 34004355

Correction: Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease.

Kekre N, Kim HT, Hofer J, Ho VT, Koreth J, Armand P, Nikiforow S, Gooptu M, Romee R, Alyea EP, Nageshwar P, Glotzbecker B, El-Jawahri A, DeFilipp Z, Soiffer RJ, Antin JH, Chen YB, Cutler C.

Bone Marrow Transplant. 2021 May. 56(5):1217. PMID: 33041331

Author Correction: Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?

Abel GA, Kim HT, Hantel A, Steensma DP, Stone R, Habib A, Ho VT, Wadleigh M, El-Jawahri A, Alyea EP, DeAngelo DJ, Koreth J, Antin JH, Soiffer RJ, Cutler C.

Leukemia. 2021 Apr. 35(4):1223. PMID: 33487633

COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience.

Maurer K, Saucier A, Kim HT, Acharya U, Mo CC, Porter J, Albert C, Cutler C, Antin JH, Koreth J, Gooptu M, Romee R, Wu CJ, Soiffer RJ, Nikiforow S, Jacobson C, Ho VT.

Blood Adv. 2021 02 09. 5(3):861-871. PMID: 33560397

Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide.

Rambaldi B, Kim HT, Reynolds C, Chamling Rai S, Arihara Y, Kubo T, Buon L, Gooptu M, Koreth J, Cutler C, Nikiforow S, Ho VT, Alyea EP, Antin JH, Wu CJ, Soiffer RJ, Ritz J, Romee R.

Blood Adv. 2021 01 26. 5(2):352-364. PMID: 33496734

Randomized Study of enterade® to Reduce Diarrhea in Patients Receiving High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation.

De Filipp Z, Glotzbecker B, Luque L, Kim HT, Mitchell KM, Cheuvront SN, Soiffer RJ.

Asian Pac J Cancer Prev. 2021 Jan 01. 22(1):301-304. PMID: 33507712

Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?

Abel GA, Kim HT, Hantel A, Steensma DP, Stone R, Habib A, Ho VT, Wadleigh M, El-Jawahri A, Alyea EP, DeAngelo DJ, Koreth J, Antin JH, Soiffer RJ, Cutler C.

Leukemia. 2021 04. 35(4):1166-1175. PMID: 33204012

Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemia.

Kim HT, Shaughnessy CJ, Rai SC, Reynolds C, Ho VT, Cutler C, Koreth J, Gooptu M, Romee R, Nikiforow S, Armand P, Alyea EP, Antin JH, Wu CJ, Soiffer RJ, Ritz J, Brown JR.

Blood Adv. 2020 09 08. 4(17):4113-4123. PMID: 32882002

Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease.